ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 130 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $65,000 | -71.0% | 23,014 | -61.9% | 0.01% | -66.7% |
| Q1 2018 | $224,000 | +28.0% | 60,378 | -0.6% | 0.02% | +157.1% |
| Q4 2017 | $175,000 | -74.0% | 60,752 | -59.4% | 0.01% | -89.1% |
| Q3 2017 | $673,000 | +171.4% | 149,817 | +177.0% | 0.06% | +178.3% |
| Q2 2017 | $248,000 | -15.9% | 54,092 | -24.3% | 0.02% | -36.1% |
| Q4 2016 | $295,000 | -83.7% | 71,428 | -67.9% | 0.04% | -81.7% |
| Q3 2016 | $1,805,000 | +165.4% | 222,833 | +155.6% | 0.20% | +129.1% |
| Q2 2016 | $680,000 | +273.6% | 87,170 | +269.5% | 0.09% | +244.0% |
| Q1 2016 | $182,000 | -11.2% | 23,591 | -61.7% | 0.02% | -69.5% |
| Q4 2013 | $205,000 | – | 61,651 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 5,191,600 | $8,255,000 | 4.47% |
| RTW INVESTMENTS, LP | 13,749,383 | $21,862,000 | 2.04% |
| ARMISTICE CAPITAL, LLC | 4,300,000 | $6,837,000 | 0.52% |
| DAFNA Capital Management LLC | 630,182 | $1,002,000 | 0.50% |
| Rock Springs Capital Management LP | 2,325,000 | $3,697,000 | 0.18% |
| 683 Capital Management, LLC | 1,000,000 | $1,590,000 | 0.10% |
| Alambic Investment Management, L.P. | 133,698 | $213,000 | 0.09% |
| South Dakota Investment Council | 3,037,004 | $7,310,000 | 0.08% |
| Alpine Global Management, LLC | 205,172 | $326,000 | 0.08% |
| Rhenman & Partners Asset Management AB | 402,800 | $640,000 | 0.07% |